+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Pharmacotherapy of obesity: options and alternatives



Pharmacotherapy of obesity: options and alternatives



Pharmacotherapy of obesity: options and alternatives: 488 pp.



This multiauthor book presents current and future options for drug treatment of obesity in the context of pathophysiology and clinical requirements and to put them into perspective against available alternative treatments. The various topics are organized into seven parts: pathophysiology of obesity, general therapeutic aspects, benefits of weight loss, drugs on the market, drugs in research and development, treatment alternatives, and future perspectives.

(PDF emailed within 0-6 h: $19.90)

Accession: 004266910

Download citation: RISBibTeXText

DOI: 10.1097/00005768-200501000-00031


Related references

Weighing the options in the pharmacotherapy of obesity. International Journal of Clinical Pharmacology and Therapeutics 39(9): 406-414, 2001

Review of pharmacotherapy options for the management of obesity. Journal of the American Association of Nurse Practitioners 28(2): 107-115, 2015

Anaesthesia and Intensive Care Residents' Perception of Simulation Training in Four Romanian Centres. Journal of Critical Care Medicine 3(1): 18-23, 2018

New targets for obesity pharmacotherapy - developing anti-obesity drugs that do not necessarily produce weight loss. Clinical Obesity 1(2-3): 61-61, 2011

Pharmacotherapy & Surgical Interventions Available for Obesity Management and Importance of Pancreatic Lipase Inhibitory Phytomolecules as Safer Anti-Obesity Therapeutics. Mini Reviews in Medicinal Chemistry (): -, 2016

Long-term pharmacotherapy for obesity in elderly patients: a retrospective evaluation of medical records from a specialized obesity outpatient clinic. Drugs & Aging 27(6): 497-506, 2010

The Update of Obesity Syndrome: Molecular Mechanism, Pathophysiology and Therapies. Topics: II. Recent Topics on Care and Treatment of the Obesity Syndrome; 3. Pharmacotherapy of obesity. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 104(4): 735-741, 2016

Pharmacotherapy options for cataplexy. Expert Opinion on PharmacoTherapy 14(7): 895-903, 2013

Novel Pharmacotherapy Options for NASH. Digestive Diseases and Sciences 61(5): 1398-1405, 2016

New pharmacotherapy options for multiple myeloma. Expert Opinion on PharmacoTherapy 17(2): 181-192, 2016

What are the pharmacotherapy options for treating prediabetes?. Expert Opinion on PharmacoTherapy 15(14): 2003-2018, 2014

Urinary incontinence: pharmacotherapy options. Annals of Medicine 43(6): 461-476, 2012

Current options in antifungal pharmacotherapy. PharmacoTherapy 28(5): 614-645, 2008

Pharmacotherapy options in rheumatoid arthritis. Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders 6: 35-43, 2013

Options for the pharmacotherapy of toxoplasmosis during pregnancy. Expert Opinion on PharmacoTherapy 2(8): 1269-1274, 2001